On January 5, 2026 NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, reported the Company will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

NeoGenomics’ management is scheduled to present and participate in a Q&A session on Tuesday, January 13, at 5:15 p.m. Pacific Time / 8:15 p.m. Eastern Time. Interested parties may access live and archived webcasts of the sessions on the "Investors" section of the company website at ir.neogenomics.com.

(Press release, NeoGenomics Laboratories, JAN 5, 2026, View Source [SID1234661737])